NCT00006332View on ClinicalTrials.gov

Treatment of Hepatocellular Carcinoma With Tetrathiomolybdate

PHASE2CompletedINTERVENTIONAL

Timeline

Start Date

Not specified

Conditions

Carcinoma, Hepatocellular

Interventions

DRUG

Tetrathiomolybdate

Trial Locations (1)

48109-0362

3912 Taubman Center, Ann Arbor

All Listed Sponsors

lead

National Center for Research Resources (NCRR)

NIH